의료기기 검사 서비스 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 서비스별, 페이즈별, 지역별, 부문 예측(2025-2030년)

Medical Device Testing Services Market Size, Share & Trends Analysis Report By Service, By Phase, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,404,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,816,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,641,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

의료기기 검사 서비스 시장의 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 의료기기 검사 서비스 시장 규모는 2025-2030년 연평균 복합 성장률(CAGR) 9.49%를 기록할 전망이며, 2030년에는 167억 8,000만 달러에 이를 전망입니다.

제품 설계의 복잡성과 엄격한 정부 규정은 의료기기 검사 서비스에 대한 수요를 촉진하고 있습니다.

전임상 비용의 대폭적인 증가는 제약회사 및 의료기기 회사의 최근 동향이며 시장 성장에 크게 공헌할 것으로 예상됩니다. 세계 헬스센터에 따르면 의약품 전임상 조사에는 73개월, 700만 달러가 필요했고 생물제제로는 47개월, 630만 달러가 필요했습니다.

현대의 의료기기는 복잡한 기능을 다수 갖추고 있어, 규제 요건에의 적합성을 체크하기 위한 적절한 검사의 필요성이 불가결해지고 있습니다. 정밀도 향상, 사용 편의성, 내구성 등의 요건을 충족시키기 위해 의료기기는 광범위한 검사를 받아야 합니다. 이는 제조업체에 경쟁 우위를 가져올 것으로 기대되고 있습니다.

한편, 생산 효율성 및 안전성에 대한 요구가 높아지고 의료기기에 대한 규제 요건이 증가하는 것은 시장 성장을 가속하는 주요 요인 중 하나입니다. 유럽의약품청(European Medicines Agency), 미국 식품의약국(U.S. Food and Drug Administration), 의약품청(Therapeutic Goods Administration), 기타 국가의 규제기관 등에서는 의료기기가 환자나 헬스케어 제공자에게 판매 및 판매되기 전에 유효성과 안전성 기준을 충족하고 있음을 증명하기 위한 문서화와 검사을 의무화하고 있습니다.

COVID-19의 대유행은 의료기기 검사 서비스에 대한 전례없는 수요를 낳았습니다. 이는 마스크, PPE, 호흡기 등 코로나19 관련 제품의 수요 증가에 힘입은 바가 큽니다. 또한 멕시코, 스페인, 프랑스 등의 국가에서는 UNE 0064-1, UNE 0064-2, AFNOR-SPEC-S76, UNE 0065 등의 적절한 사양과 규격이 발표되고 있어 마스크를 판매하기 위해서는 이러한 규격을 충족해야 합니다.

의료기기 검사 서비스 시장 보고서 하이라이트

• 서비스 분야별로는 시장은 생체 적합성 검사, 화학 검사, 미생물 및 무균 검사, 패키지 밸리데이션으로 분류됩니다.
• 단계별 부문에서는 시장이 전임상과 임상으로 분류됩니다. 2024년 시장 점유율은 임상 분야가 가장 컸습니다.
• 북미의 의료기기 검사 서비스 시장은 예측 기간 중 가장 빠른 CAGR로 성장할 것으로 예측되고 있습니다.
• 아시아태평양은 2024년에 41.18%의 최대 시장 점유율을 차지했습니다. 의료기기 검사 서비스의 진화로 이 지역의 시장 수요는 증가할 것으로 예측되고 있습니다.

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 의료기기 검사 서비스 시장의 변수, 동향 및 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련 및 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 기술의 진보
• 가격 모델 분석
• 시장 분석 도구
  • Porter's Five Forces 분석
  • SWOT 분석에 의한 PESTEL
  • COVID-19의 영향 분석

제4장 의료기기 검사 서비스 시장 : 서비스별 추정 및 동향 분석

• 의료기기 검사 서비스 시장 : 서비스별 부문 대시보드
• 의료기기 검사 서비스 시장 : 서비스별 변동 분석
• 서비스별(2018-2030년)
• 생체 적합성 검사
  • 심혈관 장치의 생체 적합성 검사
  • 정형외과용 디바이스의 생체 적합성 검사
  • 치과 임플란트 기기의 생체 적합성 검사
  • 피부 충전제의 생체 적합성 검사
  • 일반 외과 임플란트 기기의 생체 적합성 검사
  • 뇌신경외과용 임플란트 기기의 생체 적합성 검사
  • 안과용 임플란트 기기의 생체 적합성 검사
  • 기타
• 화학 검사
  • 화학특성 평가(E&L)
  • 분석 방법의 개발 및 검증
  • 독성 위험 평가 및 컨설팅
• 미생물학 및 무균 검사
  • 바이오바덴 측정
  • 발열물질 및 엔도톡신 검사
  • 무균검사과 검증
  • 항균 검사
  • 기타
• 패키지 검증

제5장 의료기기 검사 서비스 시장 : 페이즈별 추정 및 동향 분석

• 의료기기 검사 서비스 시장 : 페이즈별 부문 대시보드
• 의료기기 검사 서비스 시장 : 페이즈별 변동 분석
• 페이즈별(2018-2030년)
• 전임상
  • 작은 동물
  • 대형 동물
  • 기타
• 임상

제6장 의료기기 검사 서비스 시장 : 지역별 추정 및 동향 분석

• 지역별 시장 점유율 분석(2024년, 2030년)
• 지역별 시장 대시보드
• 세계의 지역별 시장 현황
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
  • 네덜란드
  • 벨기에
  • 스위스
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 말레이시아
  • 인도네시아
  • 싱가포르
  • 필리핀
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 콜롬비아
  • 칠레
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트
  • 이스라엘
  • 이집트

제7장 경쟁 구도

• 시장 진출기업의 분류
• 기업의 시장 점유율 분석(2024년)
• 기업 프로파일
  • SGS SA
  • Laboratory Corporation of America Holdings
  • Nelson Laboratories, LLC
  • TUV SUD
  • Charles River Laboratories
  • Element Minnetonka
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group Plc
  • North America Science Associates Inc.(NAMSA)(WuXi AppTec)

AJY

영문 목차

영문목차

Medical Device Testing Services Market Growth & Trends:

The global medical device testing services market size is expected to reach USD 16.78 billion by 2030, registering a CAGR of 9.49% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing complexity in product design and stringent government regulations are driving demand for medical device testing services.

Significant rise in preclinical spending is a recent trend among pharmaceutical and medical device companies, which is expected to significantly contribute to market growth. According to the global health center, for pharmaceuticals, supporting preclinical research required 73 months and cost USD 7 million for biologics, it took 47 months and cost USD 6.3 million.

With modern medical devices offering a host of complex functions, the need for appropriate tests to check the compliance of the device with regulatory requirements is becoming vital. In order to meet the requirement of enhanced accuracy, ease of use, and durability, medical devices need to undergo extensive tests. This is expected to deliver competitive advantage to manufacturers.

On the other hand, an increase in the need for production efficiency and safety and rising regulatory requirements for medical devices are some of the major factors driving the market growth. Regulatory bodies such as the European Medicines Agency, U.S. Food and Drug Administration, Therapeutic Goods Administration, and other country regulatory bodies require documentation and testing to certify that medical devices meet efficacy and safety standards prior they can be sold and marketed to patients and healthcare providers.

The COVID-19 pandemic has created an unprecedented demand for medical device testing services. This is largely due to the increasing demand for COVID-10 related products such as masks, PPE, & respiratory equipments. Besides, countries such as Mexico, Spain, and France have published pertinent specifications and standards, namely the UNE 0064-1, UNE 0064-2, AFNOR-SPEC-S76 & UNE 0065, which must be met until a mask can be sold.

Medical Device Testing Services Market Report Highlights:

• On the basis of service segment, the market is classified into biocompatibility testing, chemistry testing, microbiology & sterility testing, and package validation.
• On the basis of phase segment, the market is segregated into preclinical and clinical. The clinical segment accounted for the largest market share in 2024.
• The North America Medical Device Testing Services market is projected to grow at the fastest CAGR over the forecast period.
• Asia Pacific accounted for the largest market share of 41.18% in 2024. The evolving medical device testing services are expected to increase the market demand in the region, owing to established healthcare infrastructure with government initiatives.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Phase
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Medical Device Testing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Complexity in product design of medical device testing services
    • 3.2.1.2. Intense Competition in Medical Device Industry
    • 3.2.1.3. Increasing number of smaller Players lacking in-house testing capabilities
    • 3.2.1.4. Strict Approval Norms
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Legal and Regulatory Issues
    • 3.2.2.2. Delays in contractual obligations
• 3.3. Technological Advancements
• 3.4. Pricing Model Analysis
• 3.5. Market Analysis Tools
  • 3.5.1. Porter's Five Analysis
  • 3.5.2. PESTEL by SWOT Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Medical Device Testing Services Market: Service Estimates & Trend Analysis

• 4.1. Medical Device Testing Services Market, By Service: Segment Dashboard
• 4.2. Medical Device Testing Services Market, By Service: Movement Analysis
• 4.3. Medical Device Testing Services Market Estimates & Forecasts, By Service, 2018 - 2030
• 4.4. Biocompatibility Tests
  • 4.4.1. Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Cardiovascular Device's Biocompatibility Tests
    • 4.4.2.1. Cardiovascular Device's Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Orthopedic Device's Biocompatibility Tests
    • 4.4.3.1. Orthopedic Device's Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Dental Implant Devices' Biocompatibility Tests
    • 4.4.4.1. Dental Implant Devices' Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Dermal Filler's Biocompatibility Tests
    • 4.4.5.1. Dermal Filler's Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.6. General Surgery Implantation Devices Biocompatibility Tests
    • 4.4.6.1. General Surgery Implantation Devices Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.7. Neurosurgical Implantation Devices Biocompatibility Tests
    • 4.4.7.1. Neurosurgical Implantation Devices Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.8. Ophthalmic Implantation Device's Biocompatibility Tests
    • 4.4.8.1. Ophthalmic Implantation Device's Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.9. Others
    • 4.4.9.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Chemistry Test
  • 4.5.1. Chemistry Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Chemical characterization (E&L)
    • 4.5.2.1. Chemical Characterization (E&L) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Analytical method development and validation
    • 4.5.3.1. Analytical Method Development and Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Toxicological Risk Assessment and consulting
    • 4.5.4.1. Toxicological Risk Assessment and Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Microbiology & Sterility Testing
  • 4.6.1. Microbiology & Sterility Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Bioburden Determination
    • 4.6.2.1. Bioburden Determination Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Pyrogen & Endotoxin Testing
    • 4.6.3.1. Pyrogen & Endotoxin Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.4. Sterility Test & Validation
    • 4.6.4.1. Sterility Test & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.5. Antimicrobial Testing
    • 4.6.5.1. Antimicrobial Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.6. Others
    • 4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Package Validation
  • 4.7.1. Package Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Medical Device Testing Services Market: Phase Estimates & Trend Analysis

• 5.1. Medical Device Testing Services Market, By Phase: Segment Dashboard
• 5.2. Medical Device Testing Services Market, By Phase: Movement Analysis
• 5.3. Medical Device Testing Services Market Estimates & Forecasts, By Phase, 2018 - 2030
• 5.4. Preclinical
  • 5.4.1. Preclinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Small Animals
    • 5.4.2.1. Small Animals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.2. Biocompatibility Tests
      • 5.4.2.2.1. Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.3. Chemistry Tests
      • 5.4.2.3.1. Chemistry Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.4. Microbiology & Sterility Tests
      • 5.4.2.4.1. Microbiology & Sterility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Large Animals
    • 5.4.3.1. Large Animals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3.2. Biocompatibility Tests
      • 5.4.3.2.1. Biocompatibility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3.3. Chemistry Tests
      • 5.4.3.3.1. Chemistry Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3.4. Microbiology & Sterility Tests
      • 5.4.3.4.1. Microbiology & Sterility Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Clinical
  • 5.5.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Medical Device Testing Services Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. North America
  • 6.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Denmark
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Sweden
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Norway
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Netherlands
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Netherlands Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.11. Belgium
    • 6.5.11.1. Key Country Dynamics
    • 6.5.11.2. Competitive Scenario
    • 6.5.11.3. Regulatory Framework
    • 6.5.11.4. Belgium Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.12. Switzerland
    • 6.5.12.1. Key Country Dynamics
    • 6.5.12.2. Competitive Scenario
    • 6.5.12.3. Regulatory Framework
    • 6.5.12.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Australia
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. South Korea
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Malaysia
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Malaysia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Indonesia
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Indonesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.9. Singapore
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Singapore Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.10. Philippines
    • 6.6.10.1. Key Country Dynamics
    • 6.6.10.2. Competitive Scenario
    • 6.6.10.3. Regulatory Framework
    • 6.6.10.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.11. Thailand
    • 6.6.11.1. Key Country Dynamics
    • 6.6.11.2. Competitive Scenario
    • 6.6.11.3. Regulatory Framework
    • 6.6.11.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. Colombia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. Chile
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.6. Israel
    • 6.8.6.1. Key Country Dynamics
    • 6.8.6.2. Competitive Scenario
    • 6.8.6.3. Regulatory Framework
    • 6.8.6.4. Israel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.7. Egypt
    • 6.8.7.1. Key Country Dynamics
    • 6.8.7.2. Competitive Scenario
    • 6.8.7.3. Regulatory Framework
    • 6.8.7.4. Egypt Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Company Market Share Analysis, 2024
• 7.3. Company Profiles
  • 7.3.1. SGS SA
    • 7.3.1.1. Company Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Service Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. Laboratory Corporation of America Holdings
    • 7.3.2.1. Company Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Service Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. Nelson Laboratories, LLC
    • 7.3.3.1. Company Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Service Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. TUV SUD
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Service Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. Charles River Laboratories
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Service Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Element Minnetonka
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Service Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Eurofins Scientific
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Service Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Pace Analytical Services LLC
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Service Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Intertek Group Plc
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Service Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. North America Science Associates Inc. (NAMSA) (WuXi AppTec)
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Service Benchmarking
    • 7.3.10.4. Strategic Initiatives

관련자료